Skip to content
lifestyle.faithfamilyamerica.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Solid Biosciences Inc.
Solid Biosciences Reports Third Quarter 2026 Financial Results and Provides Business Updates
November 4, 2026
Solid Biosciences Announces European Commission Orphan Designation for SGT-212 and Continued Progress in the FALCON Trial in Friedreich’s Ataxia
October 26, 2026
Solid Biosciences to Present Research Across Gene Therapy Development, Delivery and Manufacturing at ESGCT 2026
October 20, 2026
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 1, 2026
Solid Biosciences to Participate at Upcoming Investor Conferences
September 2, 2026
Solid Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Updates
August 6, 2026
Solid Biosciences to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
February 12, 2026